Cargando…
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
Hyperkalaemia is a life-threatening condition, resulting from decreased renal function or dysfunctional homoeostatic mechanisms, often affecting patients with cardiovascular (CV) disease. Drugs such as renin-angiotensin-aldosterone system inhibitors (RAASi) are known to improve outcomes in CV patien...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392412/ https://www.ncbi.nlm.nih.gov/pubmed/30837802 http://dx.doi.org/10.1093/eurheartj/suy035 |